Search Results
Results found for "Novo Nordisk Foundation"
- 📰 GPCR Weekly News, May 15 to 21, 2023
Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew Hopkins, Exscientia’s founder
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Live and on-demand University courses Co-creation pathways for academic contributors Launch of The Foundry
- 📰 GPCR Weekly News, June 5 to 11, 2023
Our founder Dr. Yamina A.
- 📰 GPCR Weekly News, March 6 to 12, 2023
Fast Company has named Exscientia as one of the Most Innovative Companies of 2023 Dirk Loeffert CEO & Founder
- 📰 GPCR Weekly News, September 4 to 10, 2023
Yamina Berchiche, Founder and Director of Dr.
- The Hidden Cost of Ambition in Biotech Leadership
Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not
- 📰 GPCR Weekly News, May 8 to 14, 2023
Achievement in Collaboration to Enable DEL for Membrane Proteins Professor Andrew Hopkins, Exscientia’s founder
- 📰 GPCR Weekly News, February 5 to 11, 2024
April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join our Founder Dr.
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Inversago Pharma’s INV-347 improves metabolic dysfunction in obese mice Aneesh Karatt Vellatt (CSO & Co-Founder Supplier at Prendio Crinetics Pharmaceuticals announces executive departure Call for GPCR Papers Deadline: Nov
- 📰 GPCR Weekly News, February 12 to 18, 2024
GPCR founder Dr.
- 📰 GPCR Weekly News, June 17 to 23, 2024
pyroglutamylated RF-amide peptide QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Yamina Berchiche, our founder.
